Ventyx Biosciences Reports Fourth Quarter and Full Year
Ventyx to host virtual investor event on March 11th to provide clinical updates on our NLRP3 portfolio and from the open-label extension of the VTX002...
Source: globenewswire.com
📰 Researchand Development News
Researchand Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Researchand Development. Real-time updates on events, politics, business and more.
Coal Tar Pitch Market Size to Hit US$ 6.09 Billion, Globally, by 2031, Expanding at a CAGR of 4.5% Says, Market Data Library
Coal tar pitch is a dark, viscous liquid that is a byproduct of the production of coke and coal tar. It is used in a variety of applications, including asphalt, roofing materials, paints and coatings, and carbon electrodes. The global coal tar pitch market is expected to grow at a CAGR of 4.5% from 2022 to 2031, driven by the increasing demand for coal tar pitch from end-use industries such as the aluminum, construction, and electrical industries.Brooklyn, New York, Aug. 25, 2023 (GLOBE NEWSWIRE
Source: yahoo.com
Ventyx Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress
Phase 2 trials of VTX958 are ongoing in plaque psoriasis, Crohn’s disease and psoriatic arthritis, with topline data in plaque psoriasis expected in Q4 2023 The Phase 2 trial of VTX002 in... | May 11, 2023
United States Raju Mohan Ventyx Biosciences Ventyx Biosciences Inc Exchange Commission Oppilan Pharma Limited
Source: marketscreener.com